Study ties diabetes, obesity to higher risk of cancer recurrence

08/14/2013 | MedWire News (U.K.)

A study in the Japanese Journal of Clinical Oncology revealed patients with renal cell carcinoma and type 2 diabetes were more than twice as likely to experience cancer recurrence than those without diabetes. Researchers also found obese RCC patients had more than a fourfold increased risk of recurrence compared with nonobese patients. Obese patients with diabetes also showed a lower five-year recurrence-free survival rate of 75.3%, compared with 91.9% in those without diabetes, researchers said.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY